Three new academic members at Louvain Drug Reasearch Institute

Bruxelles Woluwe

On September 1, 2016, three young researchers, Séverine Henrard, Laure Bindels and Julian Leprince, joined the Louvain Drug Research Institute as PI to pursue their research.

Séverine Henrard holds a master’s degree in clinical biomedical sciences, a master’s degree in public health (clinical research, epidemiology and health services research), and a master’s degree in biostatistics. Dr Henrard obtained her PhD in medical sciences at UCL: she studied the impact of a rare disease on public health, using the case of haemophilia, at the Institute of Health and Society of UCL and at the Haematology department of Saint-Luc university hospital. She then conducted her postdoctoral research at the University of Leuven. She is now conducting her research in the field of pharmaco-epidemiology at the CLIP research group of LDR,I with a special interest in rare and chronic diseases. http://uclouvain.be/severine.henrard

Julian Leprince graduated as a dentist in 2006. While specialising in the clinics part time, he received an FNRS fellowship to study the photopolymerization process of dental resin-based composites and received his PhD in Dental Sciences in 2010. He then was awarded a BAEF fellowship to support a one-year post-doctoral stay at the Arthur Dugoni School of Dentistry, San Francisco, where he broadened his field of expertise to dental pulp biology and stem cells. Upon his return in 2011 and thanks to an FNRS post-doctoral fellowship, he expanded the UCL dental research group by combining both research avenues: dental biomaterials and pulp biology. In 2015, he was appointed a permanent position at the UCL dental school (Cliniques universitaires St Luc), and is since willing to develop clinical research activities as well. A grant from the St-Luc foundation gave him the chance to pursue his lab research part time. The research activity of his group (http://drim-ucl.be/fr/) is focused on connecting laboratory and clinical research, towards the global objective of improving the treatment of the consequences of dental caries.

Laure Bindels is a pharmacist who trained at the Université catholique de Louvain, Belgium. During her PhD, she focussed her research on the therapeutic interest of prebiotics and probiotics in the control of tumour progression and associated cachexia. She then moved to a postdoctoral position at the University of Nebraska-Lincoln, USA, where she studied the role of the gut microbiota in the metabolic benefits of resistant starches. She has recently join the Metabolism and Nutrition Research Group, where she is exploring the mechanisms linking the gut microbiota, cancer and associated cachexia and inflammation using among others, next-generation sequencing and metabolomics approaches. http://www.uclouvain.be/laure.bindels
 

 

 

 

Published on January 16, 2017